{
    "clinical_study": {
        "@rank": "132789", 
        "arm_group": {
            "arm_group_label": "failure to respond to RF ablation", 
            "description": "patients undergoing endoscopic RF ablation therapy with persistent BE with HGD or IMCA despite 2 or more serial RF ablation treatment sessions"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether cryotherapy is effective in the treatment\n      of persistent high grade dysplasia (HGD) or early esophageal adenocarcinoma (IMCA) in\n      patients who have not responded to radiofrequency ablation (RFA)."
        }, 
        "brief_title": "Cryotherapy -BEATS-RF Ablation Trial", 
        "completion_date": {
            "#text": "June 2019", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Barrett's Esophagus With Persistent Dysplasia or", 
            "Early Esophageal Adenocarcinoma After Radio Frequency Ablation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Adenocarcinoma", 
                "Barrett Esophagus"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age > 18 years old\n\n          -  Able to provide informed consent\n\n          -  Patients with unifocal or multifocal BE with HGD or IMCA who have        failed at\n             least 2 serial RFA therapy.\n\n          -  Patients who refused esophagectomy or deemed inoperable or whose BE dysplasia is not\n             amenable to endoscopic mucosal resection (EMR) treatment alone due to: (1) extensive\n             multifocal lesions (2) severe coagulopathy or any medical condition deemed high risk\n             for EMR (3) patient refuses EMR\n\n          -  Patients with a nodular BE lesions may undergo clinically-indicated EMR and still be\n             eligible for enrollment as long as they have  BE-HGD lesion/s that are still\n             candidate for ablative treatment\n\n        Exclusion Criteria:\n\n          -  Age younger than 18 years old\n\n          -  Life expectancy less than 12 months\n\n          -  Pregnancy\n\n          -  Presence of esophageal varices\n\n          -  Esophageal stricture precluding passage of an endoscope and suction tubing\n\n          -  Any procedure that has impeded normal gastric emptying or limited gastric volume\n             distention, including but not limited to gastric bypass, stomach stapling,\n             gastrojejunostomy or  any disease state has significantly reduced the elasticity in\n             the GI tract (e.g. Marfan's syndrome, Scleroderma or any Connective Tissue Disease)\n\n          -  Esophageal cancer (T2 and above)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "patients with persistent BE with HGD or IMCA despite 2 or more serial RF ablation\n        treatment sessions in a cohort of patients undergoing endoscopic therapy."
            }
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01882478", 
            "org_study_id": "12-006030"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Barrett's esophagus", 
            "Early esophageal adenocarcinoma", 
            "Radio Frequency Ablation", 
            "Cryotherapy"
        ], 
        "lastchanged_date": "January 17, 2014", 
        "location": {
            "contact": {
                "email": "lutzke.lori@mayo.edu", 
                "last_name": "Lori S Lutzke", 
                "phone": "507-255-7495"
            }, 
            "facility": {
                "address": {
                    "city": "Rochester", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55905"
                }, 
                "name": "Mayo Clinic"
            }, 
            "investigator": {
                "last_name": "Kenneth K Wang, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "CryoSpray Ablation for Barrett's Esophagus After Treatment Failure With Serial RadioFrequency Ablation", 
        "overall_contact": {
            "email": "lutzke.lori@mayo.edu", 
            "last_name": "Lori S Lutzke", 
            "phone": "507-255-7495"
        }, 
        "overall_official": {
            "affiliation": "Mayo Clinic", 
            "last_name": "Kenneth K Wang, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To assess efficacy of achieving elimination of dysplasia in patients with RFA-refractory BE with HGD or IMCA", 
            "measure": "Response", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01882478"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mayo Clinic", 
            "investigator_full_name": "Kenneth K. Wang", 
            "investigator_title": "Kathy and Russ VanCleve Professor of Gastroenterology Reserach", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "To identify potential predictors of CE-D and CE-IM in patients requiring rescue CSA treatment after failed RFA therapy", 
            "measure": "Predictors of response", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "Mayo Clinic", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mayo Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}